![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 32, 20300-20307, August 7, 1998
-Cell Line
HC9
From the a Third Department of Internal Medicine, Faculty of
Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113, Japan,
d Omiya Medical Center, Jichi Medical School, Omiya, Saitama
330, Japan, f The Institute for Diabetes Care and Research, Recently, a mitochondrial mutation was found to
be associated with maternally inherited diabetes mellitus (Kadowaki,
T., Kadowaki, H., Mori, Y., Tobe, K., Sakuta, R., Suzuki, Y., Tanabe,
Y, Sakura, H., Awata, T., Goto, Y., Hayakawa, T., Matsuoka, K.,
Kawamori, R., Kamada, T., Horai, S., Nonaka, I., Hagura, R., Akanuma,
Y., and Yazaki, Y. (1994) N. Engl. J. Med. 330, 962-968). In order to elucidate its etiology, we have investigated the
involvement of mitochondrial function in insulin secretion. Culture of
the pancreatic
-cell line,
HC9, with low dose ethidium bromide
(EB) (0.4 µg/ml) for 2-6 days resulted in a substantial decrease in the transcription level of mitochondrial DNA (to 10-20% of the control cells) without changing its copy number, whereas the
transcription of nuclear genes was grossly unaffected. Electron
microscopic analysis revealed that treatment by EB caused morphological
changes only in mitochondria and not in other organelles such as
nuclei, endoplasmic reticula, Golgi bodies, or secretory granules. When the cells were treated with EB for 6 days, glucose (20 mM)
could no longer stimulate insulin secretion, while glibenclamide (1 µM) still did. When EB was removed after 3- or 6-day
treatment, mitochondrial gene transcription recovered within 2 days,
and the profiles of insulin secretion returned to normal within 7 days.
Studies with fura-2 indicated that in EB-treated cells, glucose (20 mM) failed to increase intracellular Ca2+,
while the effect of glibenclamide (1 µM) was maintained.
Our system provides a unique way to investigate the relationship
between mitochondrial function and insulin secretion.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
D. D. Arrington and R. G. Schnellmann Targeting of the molecular chaperone oxygen-regulated protein 150 (ORP150) to mitochondria and its induction by cellular stress Am J Physiol Cell Physiol, February 1, 2008; 294(2): C641 - C650. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Villegas, V. Burzio, C. Villota, E. Landerer, R. Martinez, M. Santander, R. Martinez, R. Pinto, M. I. Vera, E. Boccardo, et al. Expression of a novel non-coding mitochondrial RNA in human proliferating cells Nucleic Acids Res., December 18, 2007; 35(21): 7336 - 7347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Berdanier Mitochondrial gene expression: influence of nutrients and hormones. Experimental Biology and Medicine, November 1, 2006; 231(10): 1593 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, R. K. Wong, M. Park, J. Wu, J. R. Cook, D. A. York, S. Deng, J. Markmann, A. Naji, B. A. Wolf, et al. Leucine Regulation of Glucokinase and ATP Synthase Sensitizes Glucose-Induced Insulin Secretion in Pancreatic {beta}-Cells Diabetes, January 1, 2006; 55(1): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Park, G. H. Choi, H. I. Choi, J. Ryu, C. Y. Jung, and W. Lee Depletion of Mitochondrial DNA Causes Impaired Glucose Utilization and Insulin Resistance in L6 GLUT4myc Myocytes J. Biol. Chem., March 18, 2005; 280(11): 9855 - 9864. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Li, Q. Wang, J. Li, X. Wang, M. R. Hellmich, S. Rajaraman, G. H. Greeley Jr., C. M. Townsend Jr., and B. M. Evers Inhibition of mitochondrial gene transcription suppresses neurotensin secretion in the human carcinoid cell line BON Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G213 - G220. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Maassen, Leen. M. 't Hart, E. van Essen, R. J. Heine, G. Nijpels, R. S. Jahangir Tafrechi, A. K. Raap, G. M.C. Janssen, and H. H.P.J. Lemkes Mitochondrial Diabetes: Molecular Mechanisms and Clinical Presentation Diabetes, February 1, 2004; 53(90001): S103 - 109. [Abstract] [Full Text] |
||||
![]() |
B. Lee, P. D. Miles, L. Vargas, P. Luan, S. Glasco, Y. Kushnareva, E. S. Kornbrust, K. A. Grako, C. B. Wollheim, P. Maechler, et al. Inhibition of Mitochondrial Na+-Ca2+ Exchanger Increases Mitochondrial Metabolism and Potentiates Glucose-Stimulated Insulin Secretion in Rat Pancreatic Islets Diabetes, April 1, 2003; 52(4): 965 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noda, S. Yamashita, N. Takahashi, K. Eto, L.-M. Shen, K. Izumi, S. Daniel, Y. Tsubamoto, T. Nemoto, M. Iino, et al. Switch to Anaerobic Glucose Metabolism with NADH Accumulation in the beta -Cell Model of Mitochondrial Diabetes. CHARACTERISTICS OF beta HC9 CELLS DEFICIENT IN MITOCHONDRIAL DNA TRANSCRIPTION J. Biol. Chem., October 25, 2002; 277(44): 41817 - 41826. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Park, K.-J. Nam, J.-W. Kim, Y.-B. Lee, C.-Y. Han, J.-K. Jeong, H.-K. Lee, and Y. K. Pak Depletion of mitochondrial DNA alters glucose metabolism in SK-Hep1 cells Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E1007 - E1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eto, S. Suga, M. Wakui, Y. Tsubamoto, Y. Terauchi, J. Taka, S. Aizawa, M. Noda, S. Kimura, H. Kasai, et al. NADH Shuttle System Regulates KATP Channel-dependent Pathway and Steps Distal to Cytosolic Ca2+ Concentration Elevation in Glucose-induced Insulin Secretion J. Biol. Chem., September 3, 1999; 274(36): 25386 - 25392. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakazaki, M. Kakei, H. Ishihara, N. Koriyama, H. Hashiguchi, K. Aso, M. Fukudome, Y. Oka, T. Yada, and C. Tei Association of upregulated activity of KATP channels with impaired insulin secretion in UCP1-expressing insulinoma cells J. Physiol., May 1, 2002; 540(3): 781 - 789. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |